Antonio
Gómez Caamaño
Hospital General Universitario de Valencia
Valencia, EspañaPublicacións en colaboración con investigadores/as de Hospital General Universitario de Valencia (15)
2022
-
RENORT: a project to analyze patterns of care in radiation oncology in Spain
Clinical and Translational Oncology, Vol. 24, Núm. 7, pp. 1322-1332
2021
-
Health-related quality of life in men with localized prostate cancer treated with radiotherapy: validation of an abbreviated version of the Expanded Prostate Cancer Index Composite for Clinical Practice in Spain
Health and Quality of Life Outcomes, Vol. 19, Núm. 1
-
To the editor, response letter
Clinical and Translational Oncology
2019
-
Are there enough radiation oncologists to lead the new Spanish radiotherapy?
Clinical and Translational Oncology, Vol. 21, Núm. 12, pp. 1663-1672
-
Outcomes and prognostic factors in intermediate-risk prostate cancer: multi-institutional analysis of the Spanish RECAP database
Clinical and Translational Oncology, Vol. 21, Núm. 7, pp. 900-909
-
Survival after biochemical failure in prostate cancer treated with radiotherapy: Spanish Registry of Prostate Cancer (RECAP) database outcomes
Clinical and Translational Oncology, Vol. 21, Núm. 8, pp. 1044-1051
2018
-
Adjuvant versus salvage radiotherapy in prostate cancer: multi-institutional retrospective analysis of the Spanish RECAP database
Clinical and Translational Oncology, Vol. 20, Núm. 2, pp. 193-200
2017
-
Demand for radiotherapy in Spain
Clinical and Translational Oncology, Vol. 19, Núm. 2, pp. 204-210
2016
-
Corrigendum to "Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance". [Rep. Pract. Oncol. Radiother. 20 (2015) 259-272]
Reports of Practical Oncology and Radiotherapy
-
GRAY-B: An open label multicenter phase-2 GEM study on ipilimumab and radiation in patients with melanoma and brain metastases
Annals of Oncology, Vol. 27, pp. vi383
-
The number of risk factors is the strongest predictor of prostate cancer mortality: multi-institutional outcomes of an extreme-risk prostate cancer cohort
Clinical and Translational Oncology, Vol. 18, Núm. 10, pp. 1026-1033
2015
-
Androgen deprivation and radiotherapy in patients with prostate cancer and cardiovascular risk factors: clinical controversies
Clinical and Translational Oncology, Vol. 17, Núm. 3, pp. 223-229
-
Nomogramme für die Prognose eines biochemischen Rezidivs beim Prostatakarzinom nach Strahlentherapie und Androgendeprivationstherapie
Strahlentherapie und Onkologie, Vol. 191, Núm. 10, pp. 792-800
-
Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance
Reports of Practical Oncology and Radiotherapy, Vol. 20, Núm. 4, pp. 259-272
2014
-
Infrastructures, treatment modalities, and workload of radiation oncology departments in Spain with special attention to prostate cancer
Clinical and Translational Oncology, Vol. 16, Núm. 5, pp. 447-454